Search Site
only in current section
Advanced Search…
Log in
Toggle navigation
Home
Contents
Summary of Changes from v.11.1 to v.12.0
Abbreviations
Version Information
Assessment
ART
Readiness to Start/Maintain ART
Initiation of ART: No Prior ART Exposure
Initial Regimens: ART-naïve Adults
Primary HIV Infection (PHI)
Switch Strategies
Virological Failure
Pregnancy and HIV
ART: TB/HIV Co-infection
Post-exposure Prophylaxis (PEP)
Pre-exposure Prophylaxis (PrEP)
ARV Adverse Effects & Drug Classes
DDIs & Prescribing Issues
DDIs, Prescribing, Overview
Drug-drug interactions
ARVs & non-ARVs
Analgesics & ARVs
Anticoagulants/Antiplatelet Agents & ARVs
Antidepressants & ARVs
Antihypertensives & ARVs
Anti-infective Drugs for OIs and STIs and ARVs
Anti-malarial Drugs & ARVs
Anti-tuberculosis Drugs & ARVs
Anxiolytics & ARVs
Bronchodilators & ARVs
Contraceptives & ARVs
Corticosteroids & ARVs
COVID-19 Therapies & ARVs
Hormone Replacement Therapy (HRT) & ARVs
Immunosuppressants & ARVs
Pulmonary Antihypertensives & ARVs
Viral Hepatitis Drugs & ARVs
Other prescribing issues
ARVs: Swallowing Difficulties
ARV Dosing: Hepatic Impairment
ARV Dosing: Renal Impairment
Non-ARV Drug Dosing: Renal Insufficiency
Prescribing in Older Persons with HIV
Drug Classes To Avoid in Older Persons with HIV
Drug Classes to Deprescribe in Older Persons with HIV in Presence of Certain Conditions
Hormone Therapy: Gender Transitioning
HIV/Hep Co-infection
Clinical Management and Treatment of Viral Hepatitis Co-infections
Treatment and Monitoring of Persons with HBV/HIV Co-infection
HCV/HIV Co-infection
Treatment and Monitoring of Persons with HCV/HIV Co-infection
HCV Treatment Options
DDIs: Viral Hepatitis Drugs & ARVs
Tests: Fibrosis / Cirrhosis
Hepatitis D and E infection
Opportunistic Infections, COVID-19
Overview, When to Start ART
Immune Reconstitution Inflammatory Syndrome (IRIS)
Primary Prophylaxis of OIs
Pneumocystis jirovecii Pneumonia (PcP)
Toxoplasma gondii Encephalitis
Cryptococcosis
Candidiasis
Histoplasmosis
Talaromycosis
Herpes simplex virus (HSV)
Varicella zoster virus (VZV)
Cytomegalovirus (CMV)
Progressive Multifocal Leukoencephalopathy (PML)
Bacillary Angiomatosis
Cryptosporidiosis
Non-Tuberculous Mycobacteria (NTM)
Cystoisosporiasis
Visceral Leishmaniasis
Tuberculosis
Management of COVID-19 in persons with HIV
Management of Mpox in Persons with HIV
Co-morbidities
Co-morbidities, Overview
Substance Use: Alcohol
Opioid Addiction, Pharmacological Treatment
Cancer
Cancer: Screening Methods
Cancer: Treatment Monitoring
Lifestyle Interventions
Cardiovascular Disease
Prevention of Cardiovascular Disease (CVD)
Hypertension: Diagnosis, Grading & Management
Hypertension: Drug Sequencing Management*
DDIs: Anti-hypertensives & ARVs
Type 2 Diabetes
Dyslipidemia
Dyslipidaemia
Treatment Goals for LDL-c to Reduce Cardiovascular Risk Depending on CV Risk Estimation*
Bone Disease
Bone Disease
Vitamin D Deficiency
Fracture Reduction
Kidney disease
Kidney Disease: Definition, Diagnosis and Management
ARV-associated Nephrotoxicity
Proximal Renal Tubulopathy (PRT)
ARV dosing: renal impairment
Liver Disease
Increased ALT/AST: Work-up & Management
Liver Cirrhosis: Classification, Surveillance
Liver Cirrhosis: Management
Non-Alcoholic Fatty Liver Disease (NAFLD)
Hepatorenal Syndrome /Acute Kidney Injury (HRS-AKI)
ARV Dosing: Hepatic Impairment
Lipodystrophy and Obesity:
Hyperlactataemia and Lactic Acidosis
Travel
Travel
Antimalarials & ARVs: DDI
Vaccination
Sexual, Reproductive Health
Sexual and Reproductive Health
Sexual Dysfunction
Treatment of Sexual Dysfunction
Mental Health: Depression & Anxiety Disorders
Depression: Screening, Diagnosis and Management
Antidepressants
DDI: Antidepressants and ARVs
Anxiety Disorders: Screening and Diagnosis
Anxiety Disorders: Management
Classification, Doses and Adverse Effects of Anxiolytics and Other Medications used to Treat Anxiety
DDI: Anxiolytics & ARVs
Cognitive Impairment
Use of Patient Reported Outcome Measures (PROMs) in HIV Clinical Care
Chronic Lung Disease
Chronic Lung Disease
DDI: Bronchodilators & ARVs
DDI: Pulmonary Antihypertensives & ARVs
Managing Older Persons with HIV
Frailty
Falls
Solid Organ Transplant (SOT)
Solid Organ Transplantation (SOT)
DDI: Immunosuppressants & ARVs
Paediatric HIV Treatment
ART: Initiation and Initial Regimen
ART: Preferred & Alternative First Line Options, Formulations, Dosing
Switch Strategies, Special Situations
Adherence, Virological Failure and Second Line ART
General Principles of Postnatal Prophylaxis and Infant Feeding
References
References, Overview
Assessment of Initial & Subsequent Visits, References
ARV Treatment, References
DDIs & Other Prescribing Issues, References
Co-morbidities Prevention & Management, References
Chronic Viral Hepatitis Co-infections, References
Opportunistic Infections and COVID-19, References
Paediatric HIV Treatment References
You are here:
Home
Error
Cookies are not enabled. You must enable cookies before you can log in.
Email
Password